Literature DB >> 25344213

Metaplastic carcinoma show different expression pattern of YAP compared to triple-negative breast cancer.

Hye Min Kim1, Sang Kyum Kim, Woo Hee Jung, Ja Seung Koo.   

Abstract

The purpose of this study is to examine the expression of Yes-associated protein (YAP) in metaplastic carcinoma and compare to those of triple-negative breast carcinoma (TNBC) for investigation of its implication. Tissue microarrays containing 34 cases of metaplastic carcinoma and 175 cases of TNBC were constructed and immunohistochemical staining was used to evaluate expression of the following proteins: YAP and phosphorylated YAP (pYAP). According to immunohistochemical staining results of cytokeratin 5/6, EGFR, claudin 3, claudin 4, claudin 7, E-cadherin, STAT-1, androgen receptor, and GGT-1, metaplastic carcinoma and TNBC were sub-classified into six subtypes: basal-like type, molecular apocrine type, claudin-low type, immune-related type, mixed type, and null type. Comparing the expression of YAP and pYAP in metaplastic carcinoma and TNBC, the expression of nuclear YAP (p = 0.025), cytoplasmic pYAP (p = 0.010), and nuclear pYAP (p = 0.014) in tumor cell was higher in metaplastic carcinoma than TNBC. In metaplastic carcinoma, the nuclear YAP expression in tumor cell was associated with loss of E-cadherin (p = 0.020) and claudin type (p = 0.020), and the stromal YAP expression was associated with claudin 7 positivity (p = 0.003). In conclusion, the YAP expression in metaplastic carcinoma is higher than that in TNBC, representing the association of stemness and epithelial-mesenchymal transition features in metaplastic carcinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25344213     DOI: 10.1007/s13277-014-2735-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

1.  Molecular stratification of triple-negative breast cancers.

Authors:  Charles M Perou
Journal:  Oncologist       Date:  2011

2.  Age distribution of histologic types of breast carcinoma.

Authors:  H Stalsberg; D B Thomas
Journal:  Int J Cancer       Date:  1993-04-22       Impact factor: 7.396

3.  Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas.

Authors:  Renê Gerhard; Sara Ricardo; André Albergaria; Madalena Gomes; Alfredo Ribeiro Silva; Ângela Flavia Logullo; Jorge F Cameselle-Teijeiro; Joana Paredes; Fernando Schmitt
Journal:  Breast       Date:  2012-03-30       Impact factor: 4.380

4.  Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.

Authors:  Mark R Carter; Jason L Hornick; Susan Lester; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2006-03       Impact factor: 6.394

Review 5.  Histological and molecular types of breast cancer: is there a unifying taxonomy?

Authors:  Britta Weigelt; Jorge S Reis-Filho
Journal:  Nat Rev Clin Oncol       Date:  2009-12       Impact factor: 66.675

6.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

7.  Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition.

Authors:  H C Lien; Y H Hsiao; Y S Lin; Y T Yao; H F Juan; W H Kuo; Mien-Chie Hung; K J Chang; F J Hsieh
Journal:  Oncogene       Date:  2007-07-02       Impact factor: 9.867

8.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Authors:  Lars Zender; Mona S Spector; Wen Xue; Peer Flemming; Carlos Cordon-Cardo; John Silke; Sheung-Tat Fan; John M Luk; Michael Wigler; Gregory J Hannon; David Mu; Robert Lucito; Scott Powers; Scott W Lowe
Journal:  Cell       Date:  2006-06-30       Impact factor: 41.582

Review 9.  The epithelial-mesenchymal transition: new insights in signaling, development, and disease.

Authors:  Jonathan M Lee; Shoukat Dedhar; Raghu Kalluri; Erik W Thompson
Journal:  J Cell Biol       Date:  2006-03-27       Impact factor: 10.539

10.  Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.

Authors:  Gi Jeong Kim; Hyunki Kim; Young Nyun Park
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

View more
  9 in total

1.  Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.

Authors:  Hongbin Li; Barry M Gumbiner
Journal:  Mamm Genome       Date:  2016-09-06       Impact factor: 2.957

2.  Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases.

Authors:  Priyakshi Kalita-de Croft; Malcolm Lim; Haarika Chittoory; Xavier M de Luca; Jamie R Kutasovic; Bryan W Day; Fares Al-Ejeh; Peter T Simpson; Amy E McCart Reed; Sunil R Lakhani; Jodi M Saunus
Journal:  Ther Adv Med Oncol       Date:  2020-07-31       Impact factor: 8.168

3.  Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.

Authors:  Mary C Schroeder; Priya Rastogi; Charles E Geyer; Lance D Miller; Alexandra Thomas
Journal:  Oncologist       Date:  2018-01-12

Review 4.  A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy.

Authors:  Masahiro Shibata; Kendall Ham; Mohammad Obaidul Hoque
Journal:  Int J Cancer       Date:  2018-07-24       Impact factor: 7.396

5.  Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy.

Authors:  Patrizia Vici; Cristiana Ercolani; Anna Di Benedetto; Laura Pizzuti; Luigi Di Lauro; Francesca Sperati; Irene Terrenato; Teresa Gamucci; Clara Natoli; Franco Di Filippo; Claudio Botti; Maddalena Barba; Marcella Mottolese; Ruggero De Maria; Marcello Maugeri-Saccà
Journal:  J Exp Clin Cancer Res       Date:  2016-04-02

Review 6.  The role of Hippo signal pathway in breast cancer metastasis.

Authors:  Changran Wei; Ying Wang; Xiangqi Li
Journal:  Onco Targets Ther       Date:  2018-04-17       Impact factor: 4.147

Review 7.  Breast Cancer Stem Cells.

Authors:  Judy S Crabtree; Lucio Miele
Journal:  Biomedicines       Date:  2018-07-17

8.  The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database.

Authors:  Yongfeng Li; Meng Chen; Barbara Pardini; Mihnea P Dragomir; Anthony Lucci; George A Calin
Journal:  J Transl Med       Date:  2019-09-23       Impact factor: 5.531

9.  Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells.

Authors:  Soroush Darbankhales; Reza Mirfakhraie; Hossein Ghahremani; Mohsen Asadolahi; Kobra Saket-Kisomi; Lily Safakish; Sepideh Darbeheshti; Zahra Ganjkhanlou; Siamak Salami; Majid Sirati-Sabet
Journal:  Asian Pac J Cancer Prev       Date:  2020-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.